<?xml version='1.0' encoding='UTF-8'?>
<DOC><DOCNO> AP891120-0132 </DOCNO><FILEID>AP-NR-11-20-89 2115EST</FILEID><FIRST>r w AM-FDA-InterimCommissioner     11-20 0227</FIRST><SECOND>AM-FDA-Interim Commissioner,210</SECOND><HEAD>Benson to Serve As Interim FDA Commissioner</HEAD><DATELINE>WASHINGTON (AP) </DATELINE><TEXT>   James S. Benson, acting deputy commissioner ofthe Food and Drug Administration, will serve as interimcommissioner when the agency's current chief leaves next month,officials announced Monday.   FDA Commissioner Frank Young is to leave the post Dec. 18 tobecome a deputy assistant secretary for health in the Department ofHealth and Human Services. FDA is also part of the department.   HHS Secretary Louis Sullivan said Benson ``will assurecontinuity and strong, professional leadership'' at FDA, which wasrocked earlier this year by a generic drug scandal that has led toseveral bribery convictions and dozens of recalls.   ``He will assure that the vigorous initiatives in progress underDr. Young will continue uninterrupted,'' while a search isconducted for a permanent commissioner, Sullivan said.   Benson, in a statement, said he was honored by the appointment,adding, ``I shall do everything in my power to keep the FDA movingforward.''   Unlike Young and the commissioners before him who were appointedby the department secretary, the next FDA chief will be appointedby the president and confirmed by the Senate. The change was madein a law passed by Congress last year.   The FDA is the federal agency responsible for assuring thesafety of drugs, cosmetics, medical devices, radiological productsand most food products.</TEXT></DOC>